5-ethyl-1-ethoxymethyl-6-(phenylthio)uracil has been researched along with zidovudine in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baba, M; De Clercq, E; Miyasaka, T; Nitta, I; Sekiya, K; Shigeta, S; Takashima, H; Tanaka, H; Ubasawa, M; Walker, RT | 1 |
Baba, M; Miyasaka, T; Nakashima, H; Nitta, I; Saito, S; Sekiya, K; Takashima, H; Tanaka, H; Ubasawa, M; Walker, RT | 1 |
Anné, J; de Clercq, E; de Vreese, K; Debyser, Z; Desmyter, J; Pauwels, R; Vandamme, AM | 1 |
Baba, M; De Clercq, E; Debyser, Z; Desmyter, J; Pauwels, R | 1 |
Baba, M; De Clercq, E; Ito, M; Miyasaka, T; Shigeta, S; Tanaka, H; Ubasawa, M; Umezu, K; Walker, RT | 1 |
Goudgaon, NM; McKenna, PM; Mellors, JW; Nguyen, MH; Schinazi, RF; Shi, C | 1 |
Baba, M; Fujiwara, M; Ijichi, K; Konno, K; Shigeta, S; Yokota, T | 1 |
7 other study(ies) available for 5-ethyl-1-ethoxymethyl-6-(phenylthio)uracil and zidovudine
Article | Year |
---|---|
Synthesis and antiviral activity of deoxy analogs of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) as potent and selective anti-HIV-1 agents.
Topics: Antiviral Agents; Cells, Cultured; HIV-1; Structure-Activity Relationship; Thymine; Virus Replication | 1992 |
Specific anti-HIV-1 "acyclonucleosides" which cannot be phosphorylated: synthesis of some deoxy analogues of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine.
Topics: Animals; Antiviral Agents; Cell Line; HIV-1; Humans; Molecular Structure; Structure-Activity Relationship; Thymine; Virus Replication | 1991 |
Resistance of human immunodeficiency virus type 1 reverse transcriptase to TIBO derivatives induced by site-directed mutagenesis.
Topics: Antiviral Agents; Base Sequence; Benzodiazepines; Binding Sites; Deoxyguanine Nucleotides; Dideoxynucleotides; HIV Reverse Transcriptase; HIV-1; Imidazoles; Molecular Sequence Data; Mutagenesis, Site-Directed; Oligodeoxyribonucleotides; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Structure-Activity Relationship; Uracil; Zidovudine | 1992 |
Common features in the interaction of tetrahydroimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one and -thione and 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives with the human immunodeficiency virus type 1 reverse transcriptase.
Topics: Antiviral Agents; Benzodiazepines; Dideoxynucleotides; HIV-1; Imidazoles; Kinetics; Molecular Structure; Recombinant Proteins; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Templates, Genetic; Thymidine; Thymine Nucleotides; Uracil; Zidovudine | 1992 |
Synergistic inhibition of human immunodeficiency virus type 1 replication by 5-ethyl-1-ethoxymethyl-6-(phenylthio)uracil (E-EPU) and azidothymidine in vitro.
Topics: Antiviral Agents; Cells, Cultured; Cytopathogenic Effect, Viral; Drug Synergism; HIV-1; Humans; Uracil; Virus Replication; Zidovudine | 1991 |
Resistance of human immunodeficiency virus type 1 to acyclic 6-phenylselenenyl- and 6-phenylthiopyrimidines.
Topics: Antiviral Agents; Drug Resistance; HIV-1; Humans; Mutation; Organoselenium Compounds; Structure-Activity Relationship; Uracil; Zidovudine | 1994 |
Different properties of wild type and drug-resistant mutants of human immunodeficiency virus type 1 reverse transcriptase in vitro.
Topics: Antiviral Agents; Cells, Cultured; DNA, Viral; Drug Resistance, Microbial; HIV Infections; HIV-1; Humans; Mutation; Proviruses; RNA-Directed DNA Polymerase; Uracil; Virus Replication; Zidovudine | 1996 |